Bioethics is trading at 0.0051 as of the 6th of February 2026. This is a No Change since the beginning of the trading day. The stock's open price was 0.0051. Bioethics has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 8th of November 2025 and ending today, the 6th of February 2026. Click here to learn more.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States. The company has 1.14 M outstanding shares. More on Bioethics
Bioethics [BOTH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioethics conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 1.14 M outstanding shares.
Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations.
Check Bioethics Probability Of BankruptcyOwnership AllocationBioethics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.53 percent of Bioethics outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Bioethics Ownership Details
About 89.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.09. Bioethics last dividend was issued on the 2nd of November 2020. The entity had 1:10 split on the 2nd of November 2020. It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.The quote for Bioethics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioethics please contact Mark Scharmann at 801 399 3632.
Bioethics Investment Alerts
Bioethics generated a negative expected return over the last 90 days
Bioethics has some characteristics of a very speculative penny stock
Bioethics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0.
Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations.
Roughly 89.0% of the company shares are held by company insiders
Bioethics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Technical Drivers
As of the 6th of February, Bioethics shows the Risk Adjusted Performance of (0.08), mean deviation of 2.97, and Standard Deviation of 12.26. Bioethics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioethics Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Bioethics price patterns.
Bioethics Outstanding Bonds
Bioethics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioethics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioethics bonds can be classified according to their maturity, which is the date when Bioethics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Bioethics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bioethics pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Bioethics' time-series forecasting models are one of many Bioethics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioethics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in Bioethics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Stock Tickers Now
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Other Information on Investing in Bioethics Pink Sheet
Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.